National Institute of Diabetes and Digestive and Kidney Diseases. IgA nephropathy. https://www.niddk.nih.gov/health-information/kidney-disease/iga-nephropathy
Lv J, et al. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: The TESTING randomized clinical trial. JAMA 2017; 318:432–442. doi: 10.1001/jama.2017.9362
Singh AK, et al. Daprodustat for the treatment of anemia in patients undergoing dialysis. N Engl J Med [published online ahead of print November 5, 2021]. doi: 10.1056/NEJMoa2113379; https://www.nejm.org/doi/10.1056/NEJMoa2113379
Singh AK, et al. Daprodustat for the treatment of anemia in patients not undergoing dialysis. N Engl J Med [published online ahead of print November 5, 2021]. doi: 10.1056/NEJMoa2113380; https://www.nejm.org/doi/10.1056/NEJMoa2113380
Agarwal R, et al. Chlorthalidone for hypertension in advanced chronic kidney disease. N Engl J Med [published online ahead of print November 5, 2021]. doi: 10.1056/NEJMoa2110730; https://www.nejm.org/doi/10.1056/NEJMoa2110730
Anker SD, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med 2021; 385:1451–1461. doi: 10.1056/NEJMoa2107038
Jayne DRW, et al. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med 2021; 384:599–609. doi: 10.1056/NEJMoa2023386
US Food and Drug Administration. FDA approves add-on drug for adults with rare form of blood vessel inflammation. October 13, 2021. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-add-drug-adults-rare-form-blood-vessel-inflammation